FindTrial
Sign In

The effect of aromatherapy in symptom management of patients with hematopoietic stem cell transplantation during isolation

The effect of aromatherapy in symptom management of patients with hematopoietic stem cell transplantation during isolation

Status
Unknown
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053322
Enrollment
Unknown
Registered
2021-11-18
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic stem cell transplantation

Interventions

Experimental group:Lavender inhalation
Control group:Routine care

Sponsors

The First Affiliated Hospital of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with hematological malignancies undergoing allogeneic hematopoietic stem cell transplantation; 2. > 18 years old, and no gender limitation; 3. Patients who will fill out the questionnaire; 4. Patients who volunteered to participate in this experiment.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to lavender essential oil; 2. Patients whose estimated survival time is less than one month; 3. Patients with a history of anxiety or depression before pretreatment; 4. Patients with other estrogen-dependent tumors.

Design outcomes

Primary

MeasureTime frame
Sleep;Anxiety and depression;—

Secondary

MeasureTime frame
pain;Nausea and vomiting;Hematopoietic stem cell implantation;—

Countries

China

Contacts

Public ContactLiu Juanjuan

The First Affiliated Hospital of Zhejiang University

hjy815@yeah.net+86 13732254945

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026